Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycyl-tRNA synthetase 1 pseudogene 1 (GARS1P1)
- Target
- GARS1P1
- Molecular classification
- Other (Pseudogene)
01
Overview
GARS1P1 is a human pseudogene and a noncoding DNA segment related to the glycyl-tRNA synthetase 1 gene (GARS1). Unlike its protein-coding parent gene, GARS1P1 does not generate a functional protein and is not implicated in human disease or therapeutic intervention. While GARS1 is a critical enzyme in protein synthesis and is involved in certain inherited neuropathies, GARS1P1 is considered a genetic remnant with no known functional role.
- Other names
- GARSP1glycyl-tRNA synthetase pseudogene 1GARS1P1
Beyond the preview
Go deeper on Glycyl-tRNA synthetase 1 pseudogene 1 (GARS1P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glycyl-tRNA synthetase 1 pseudogene 1 (GARS1P1).